Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 73,683 | 35,740 | 27,733 | 13,487 | -1,956 |
| Depreciation Amortization | 59,859 | 29,581 | 120,090 | 88,994 | 56,325 |
| Income taxes - deferred | -3,205 | -940 | 1,369 | -720 | 1,173 |
| Accounts receivable | -2,390 | 488 | 10,999 | 10,992 | 4,100 |
| Other Working Capital | 48,452 | 20,481 | 83,470 | 66,095 | 38,719 |
| Other Operating Activity | -14,335 | -9,561 | 33,355 | 19,356 | 27,265 |
| Operating Cash Flow | $162,064 | $75,789 | $277,016 | $198,204 | $125,626 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -3,477 | -2,529 | -24,478 | -26,794 | -28,621 |
| PPE Investments | -225,346 | -142,864 | -118,153 | 26,455 | 15,356 |
| Other Investing Activity | 1,252 | 1,285 | 108,663 | 16,943 | 10,180 |
| Investing Cash Flow | $-227,571 | $-144,108 | $-33,968 | $16,604 | $-3,085 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 260,000 | 141,000 | 1,186,537 | 1,025,527 | 227,000 |
| Debt Repayment | -183,743 | -59,887 | -1,349,918 | -911,946 | -346,200 |
| Common Stock Issued | 1,697 | 1,499 | 4,163 | 3,397 | 229 |
| Common Stock Repurchased | -12,788 | -12,788 | -7,946 | N/A | N/A |
| Dividend Paid | -14,805 | -7,399 | -17,706 | -11,048 | -4,414 |
| Other Financing Activity | 0 | 0 | -65,012 | -11,515 | -2,156 |
| Financing Cash Flow | $50,361 | $62,425 | $-249,882 | $94,415 | $-125,541 |
| Exchange Rate Effect | -127 | -8 | 97 | -15 | -189 |
| Beginning Cash Position | 66,502 | 66,502 | 73,239 | 73,239 | 73,239 |
| End Cash Position | 51,229 | 60,600 | 66,502 | 382,447 | 70,050 |
| Net Cash Flow | $-15,273 | $-5,902 | $-6,737 | $309,208 | $-3,189 |
| Free Cash Flow | |||||
| Operating Cash Flow | 162,064 | 75,789 | 277,016 | 198,204 | 125,626 |
| Capital Expenditure | -276,726 | -171,647 | -219,450 | -49,223 | -32,930 |
| Free Cash Flow | -114,662 | -95,858 | 57,566 | 148,981 | 92,696 |